GAMCO Investors’s Trillium Therapeutics Inc. TRIL Stock Holding History

GAMCO Investors’s Portfolio TRIL Stock Details TRIL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-199,911	Closed	-$3.51M	–	966
2021 Q3	$3.51M	Buy	+199,911	New	+$2.34M	0.03%	409

Other funds holding TRIL

Optiver Holding Amsterdam, Netherlands $289B AUM 33.63% 1-Year Est. Return

GAMCO Investors's TRIL Position: Q4 2021 in Review

GAMCO Investors sold out of Trillium Therapeutics Inc. (TRIL) in Q4 2021, closing a stake of 199,911 shares — an estimated $3.51M sold.

GAMCO Investors first reported a position in TRIL in Q3 2021 and held it in 1 quarter. The position peaked at $3.51M in Q3 2021. 2 funds tracked by Wall St. Rank hold TRIL as of Q4 2021.

GAMCO Investors reported no remaining Trillium Therapeutics Inc. position as of Q4 2021 after selling out during the quarter.
GAMCO Investors sold 199,911 Trillium Therapeutics Inc. shares in Q4 2021, an estimated $3.51M.
GAMCO Investors first reported a position in Trillium Therapeutics Inc. in Q3 2021 and held it in 1 quarter.
GAMCO Investors's Trillium Therapeutics Inc. position peaked at $3.51M in Q3 2021.
2 funds tracked by Wall St. Rank held Trillium Therapeutics Inc. as of Q4 2021.

Based on GAMCO Investors's 13F filing for Q4 2021, filed 11 Feb 2022.